ANGLE plc (LON:AGL – Get Free Report) passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 2.35 and traded as high as GBX 2.90. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares.
ANGLE Trading Down 11.3%
The stock has a 50-day moving average of GBX 2.35 and a 200 day moving average of GBX 2.35. The stock has a market cap of £7.58 million, a PE ratio of -0.49 and a beta of 0.22. The company has a quick ratio of 6.17, a current ratio of 2.76 and a debt-to-equity ratio of 25.25.
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
See Also
- Five stocks we like better than ANGLE
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
